The German pharmaceutical company Bayer’s acarbose product Glucobay® has been the bestselling antidiabetic medication in China. It reduces glucose uptake mainly and is particularly suitable for the traditional Chinese diet high in carbohydrates. In the first nine months of 2018, the product recorded a sales revenue of nearly 395,000 yuan in the main public hospitals in China.
…. more: Statista.com (Quelle/Source)